Sustained effects of gene-activated matrices after CNS injury.
about
Gene delivery strategies to promote spinal cord repairTissue engineering and regenerative medicine -where do we stand?Plasmid releasing multiple channel bridges for transgene expression after spinal cord injuryA phage-targeting strategy for the design of spatiotemporal drug delivery from grafted matricesImmunomodulatory activity of a Chinese herbal drug Yi Shen Juan Bi in adjuvant arthritis.Two and three-dimensional gene transfer from enzymatically degradable hydrogel scaffoldsThe noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials.Cytoplasmic expression systems triggered by mRNA yield increased gene expression in post-mitotic neurons.Gene delivery from polymer scaffolds for tissue engineering.Gene therapy used for tissue engineering applications.Gene transfer strategies in tissue engineeringMatrices and scaffolds for DNA delivery in tissue engineeringDNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells.Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection.Engineering extracellular matrix through nanotechnology.The deployment of adenovirus-containing gene activated matrices onto severed axons after central nervous system injury leads to transgene expression in target neuronal cell bodiesLentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels.A slow-release fibrin matrix increases adeno-associated virus transduction of wound repair cells in vivo.Effect of sustained PDGF nonviral gene delivery on repair of tooth-supporting bone defects
P2860
Q26825131-5B7990D2-DFB7-4668-AA9E-054B428C1779Q28661692-D547D45F-414B-494C-B46D-A9E65DCC8705Q33713237-71951C02-8ABD-46E9-878A-E8FC7D7EB30AQ33823155-467E512F-AB50-4880-8E10-CE78F74764E0Q34007082-985635F1-E4E1-4294-8E85-7972DBDF7E18Q34091796-81EA1AEB-FA91-4241-A846-244BA9E6AEE5Q34167850-F466B86A-3826-4933-B164-592DFCC006E2Q34766975-261116DD-0AAF-4E8F-9A4D-DAB09C330AAFQ36314939-D565D2D5-FDA3-46C7-9B00-ADFF3964FBF4Q36748645-794FA62F-E836-452A-83F8-38F1645C745DQ36815336-4DB54902-0164-4814-A0EB-3827D9F41E8BQ36826532-67E39F53-5EA6-4069-B823-47832B66AA7FQ37095873-DF8C67A2-D1DC-4BAA-93F5-811950D9930FQ37110938-333C1684-2FE0-4010-B7F7-B871F5941EBBQ37791271-A164CB1E-0E4B-4554-BDBF-8C7190691C30Q39841044-FE7E1F82-D3E0-4BC9-8FB5-A2826FE6AC13Q40295130-9D04BB30-6D10-4178-90A7-B703B541E7DEQ42259507-527330D1-5657-4F4A-94BA-78DA58177425Q42327817-B5AF7A25-A4B9-493E-AC11-77D5F4ABD854
P2860
Sustained effects of gene-activated matrices after CNS injury.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Sustained effects of gene-activated matrices after CNS injury.
@en
Sustained effects of gene-activated matrices after CNS injury.
@en-gb
type
label
Sustained effects of gene-activated matrices after CNS injury.
@en
Sustained effects of gene-activated matrices after CNS injury.
@en-gb
prefLabel
Sustained effects of gene-activated matrices after CNS injury.
@en
Sustained effects of gene-activated matrices after CNS injury.
@en-gb
P2093
P356
P1476
Sustained effects of gene-activated matrices after CNS injury.
@en
P2093
Gonzalez AM
Greenlees L
P304
P356
10.1006/MCNE.2001.0975
P50
P577
2001-04-01T00:00:00Z